Form D · Biotechnology

Los Angeles Project Inc

Austin, TX · CIK 0002136290

Offering snapshot reported Jun 8, 2026 · SEC filing

Reported sold
$4.91M
Offering amount: $6.91M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 26, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 8, 2026Initial$4,909,088No comparison13SEC filing
Jun 5, 2026Initial$1,475,000No comparison5SEC filing
Jun 5, 2026Initial$625,000No comparison4SEC filing
Jun 5, 2026Initial$730,000No comparison4SEC filing
Jun 5, 2026Initial$79,100No comparison1SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-586556

Source: Form D, filed Jun 8, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Josette Zayner Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1905 Kramer Lane B850
Austin, TX, 78758